Cardinal Health, Inc. (NYSE:CAH) is one of the 11 stocks on Jim Cramer’s radar. Calling Cardinal Health, Inc.’s (NYSE:CAH) upcoming Investor Day a possible needle mover, Cramer said: “Now ...

Cardinal Health (NYSE:CAH) recently launched the Kendall DL™ Multi System, a notable advancement in patient monitoring technology aimed at improving clinical efficiency and patient safety.

Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac ...

We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks that ...

Cardinal Health insiders own 0.4% of the company, currently worth about US$134m based on the recent share price. I like to see this level of insider ownership, ...

Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the ...

Cardinal Health (NYSE:CAH) recently approved an increase in its quarterly dividend, a move that aligns with the company's notable 21% price increase last quarter. This uptick came despite a ...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend ...

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17. Sales remained flat at $54.9 billion, missing ...

The company raised and narrowed its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health to $8.05 to $8.15, from $7.85 to $8.00. The updated fiscal ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $54.88 billion. Its non-GAAP profit ...

Cardinal Health forecast double-digit growth in earnings for the fiscal year 2026, despite a hit of $200 million to $300 million due to extreme tariff rates, the drug distributor said on Thursday.